Zobrazeno 1 - 10
of 29
pro vyhledávání: '"V. W., Rusch"'
Autor:
M. S., Tsao, H., Asamura, A. C., Borczuk, S., Dacic, S. S., Devesa, K. M., Kerr, H., MacMahon, V. W., Rusch, J. M., Samet, G. V., Scagliotti, W. D., Travis, P. E. Y., Van Schil, Y., Yatabe, A., Znaor
Publikováno v:
WHO/IARC Classification of Tumours; 2021, Vol. 5, p20-28, 9p
Autor:
D, Molena, H H, Sun, A S, Badr, B, Mungo, I S, Sarkaria, P S, Adusumilli, M S, Bains, V W, Rusch, D H, Ilson, N P, Rizk
Publikováno v:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 27(4)
Chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rates of pathological complete response. A pathological complete response is recognized to be an important predictor of improved survival, to the extent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68612fd2345da67112d22b5e3dc45edb
https://pubmed.ncbi.nlm.nih.gov/24592977
https://pubmed.ncbi.nlm.nih.gov/24592977
Autor:
N, Gerber, D H, Ilson, A J, Wu, Y Y, Janjigian, D P, Kelsen, J, Zheng, Z, Zhang, M S, Bains, N, Rizk, V W, Rusch, K A, Goodman
Publikováno v:
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 27(3)
This study looks at toxicity and survival data when chemoradiation (CRT) is delivered using intensity-modulated radiation therapy (IMRT) after induction chemotherapy. Forty-one patients with esophageal adenocarcinoma treated with IMRT from March 2007
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82fa1d70f5f2cf2a1dc19c46cddea765
https://pubmed.ncbi.nlm.nih.gov/23796070
https://pubmed.ncbi.nlm.nih.gov/23796070
Autor:
V. W. Rusch
Publikováno v:
Chest. 106:359S-362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::095aacddc7c0e86085ef8b853e57d068
https://doi.org/10.1378/chest.106.6.359s
https://doi.org/10.1378/chest.106.6.359s
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(10)
Studies described here sought to evaluate the therapeutic potential of a new 10-deazaaminopterin analogue, 10-propargyl-10-deazaaminopterin (PDX), alone and in combination with platinum compounds in the treatment of human pleural mesothelioma. In vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1840b2f81ad90932691b7d03a8b36727
https://pubmed.ncbi.nlm.nih.gov/11595715
https://pubmed.ncbi.nlm.nih.gov/11595715
Autor:
V W, Rusch
Publikováno v:
Chest surgery clinics of North America. 9(2)
Surgical resection is considered a mainstay for the treatment of malignant pleural mesothelioma (MPM), but the indications for extrapleural pneumonectomy in this disease remain controversial. In general terms, an operation contributes to cancer manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e8b90766bfbf808c1f15ad04dce7a1d
https://pubmed.ncbi.nlm.nih.gov/10365266
https://pubmed.ncbi.nlm.nih.gov/10365266
Autor:
V W, Rusch
Publikováno v:
Seminars in thoracic and cardiovascular surgery. 9(4)
Pleurectomy/decortication is a frequently performed operation for patients with diffuse malignant pleural mesothelioma (DMPM). It has a low surgical mortality rate (less than 5%), but is associated with a significant risk of local recurrence. To date
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a35c1ff2a5a17625c7a4723685ba3d61
https://pubmed.ncbi.nlm.nih.gov/9352954
https://pubmed.ncbi.nlm.nih.gov/9352954
Autor:
D, Amar, N, Roistacher, M E, Burt, V W, Rusch, M S, Bains, D H, Leung, R J, Downey, R J, Ginsberg
Publikováno v:
The Annals of thoracic surgery. 63(5)
This prospective study was designed to determine whether diltiazem is superior to digoxin for the prophylaxis of supraventricular dysrhythmias (SVD) after pneumonectomy or extrapleural pneumonectomy (EPP) and to assess the influence of these drugs on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::564d0bdc5b0bbf44fcb36b72f495a325
https://pubmed.ncbi.nlm.nih.gov/9146330
https://pubmed.ncbi.nlm.nih.gov/9146330
Autor:
V W, Rusch
Publikováno v:
Chest. 108(4)
Investigation of the behavior and treatment of the diffuse malignant pleural mesothelioma (MPM) is hindered by the lack of an accurate universally accepted staging system. To address this problem, the International Mesothelioma Interest Group (IMIG)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2aeb801d9403a3511a75631dc5743eae
https://pubmed.ncbi.nlm.nih.gov/7555156
https://pubmed.ncbi.nlm.nih.gov/7555156
Autor:
V W, Rusch
Publikováno v:
Chest. 107
Surgical resection remains an important form of treatment for pulmonary metastases from a variety of solid tumors. The most significant factors in selecting patients for operation include control of the primary tumor, ability to resect all metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d7b79af475a6dd4c1a414b430aac862
https://pubmed.ncbi.nlm.nih.gov/7781414
https://pubmed.ncbi.nlm.nih.gov/7781414